• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜伏期逆转加自然杀伤细胞减少体内 HIV 储存库。

Latency reversal plus natural killer cells diminish HIV reservoir in vivo.

机构信息

Department of Medicine, Division of Infectious Diseases, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA, 90095, USA.

出版信息

Nat Commun. 2022 Jan 10;13(1):121. doi: 10.1038/s41467-021-27647-0.

DOI:10.1038/s41467-021-27647-0
PMID:35013215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8748509/
Abstract

HIV is difficult to eradicate due to the persistence of a long-lived reservoir of latently infected cells. Previous studies have shown that natural killer cells are important to inhibiting HIV infection, but it is unclear whether the administration of natural killer cells can reduce rebound viremia when anti-retroviral therapy is discontinued. Here we show the administration of allogeneic human peripheral blood natural killer cells delays viral rebound following interruption of anti-retroviral therapy in humanized mice infected with HIV-1. Utilizing genetically barcoded virus technology, we show these natural killer cells efficiently reduced viral clones rebounding from latency. Moreover, a kick and kill strategy comprised of the protein kinase C modulator and latency reversing agent SUW133 and allogeneic human peripheral blood natural killer cells during anti-retroviral therapy eliminated the viral reservoir in a subset of mice. Therefore, combinations utilizing latency reversal agents with targeted cellular killing agents may be an effective approach to eradicating the viral reservoir.

摘要

HIV 难以根除,因为潜伏感染细胞的寿命很长。先前的研究表明,自然杀伤细胞对于抑制 HIV 感染很重要,但尚不清楚在停止抗逆转录病毒治疗时,给予自然杀伤细胞是否可以减少病毒反弹。在这里,我们展示了同种异体人外周血自然杀伤细胞的给药可以延迟感染 HIV-1 的人源化小鼠中断抗逆转录病毒治疗后的病毒反弹。利用基因编码病毒技术,我们表明这些自然杀伤细胞有效地减少了从潜伏状态中反弹的病毒克隆。此外,在抗逆转录病毒治疗期间,包含蛋白激酶 C 调节剂和潜伏逆转剂 SUW133 以及同种异体人外周血自然杀伤细胞的“踢杀”策略可以消除一部分小鼠中的病毒库。因此,利用潜伏逆转剂与靶向细胞杀伤剂的组合可能是消除病毒库的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/7c07a751ce3f/41467_2021_27647_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/ec12aa5c4647/41467_2021_27647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/332012eb8ddc/41467_2021_27647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/c8d49233e80e/41467_2021_27647_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/a5679330fd0d/41467_2021_27647_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/a6ea1a4709ef/41467_2021_27647_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/7c07a751ce3f/41467_2021_27647_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/ec12aa5c4647/41467_2021_27647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/332012eb8ddc/41467_2021_27647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/c8d49233e80e/41467_2021_27647_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/a5679330fd0d/41467_2021_27647_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/a6ea1a4709ef/41467_2021_27647_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8abd/8748509/7c07a751ce3f/41467_2021_27647_Fig6_HTML.jpg

相似文献

1
Latency reversal plus natural killer cells diminish HIV reservoir in vivo.潜伏期逆转加自然杀伤细胞减少体内 HIV 储存库。
Nat Commun. 2022 Jan 10;13(1):121. doi: 10.1038/s41467-021-27647-0.
2
Tracking HIV Rebound following Latency Reversal Using Barcoded HIV.使用带有条码的 HIV 追踪潜伏逆转后 HIV 的反弹
Cell Rep Med. 2020 Dec 22;1(9):100162. doi: 10.1016/j.xcrm.2020.100162.
3
Establishment of a Novel Humanized Mouse Model To Investigate Activation and Depletion of Patient-Derived HIV Latent Reservoirs.建立一种新型人源化小鼠模型以研究患者源性 HIV 潜伏库的激活和耗竭。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.02051-18. Print 2019 Mar 15.
4
TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4 T Cells.TLR1/2 激动剂增强 HIV-1 潜伏期的逆转,并促进 NK 细胞诱导抑制 HIV-1 感染的自体 CD4 T 细胞。
J Virol. 2021 Aug 10;95(17):e0081621. doi: 10.1128/JVI.00816-21.
5
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal .白细胞介素 15 刺激的自然杀伤细胞在潜伏期逆转后清除 HIV-1 感染的细胞。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00235-18. Print 2018 Jun 15.
6
Bryostatin-1 Decreases HIV-1 Infection and Viral Production in Human Primary Macrophages.Bryostatin-1 可降低人原代巨噬细胞中的 HIV-1 感染和病毒产生。
J Virol. 2022 Feb 23;96(4):e0195321. doi: 10.1128/JVI.01953-21. Epub 2021 Dec 8.
7
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.在用帕比司他进行潜伏逆转治疗期间,先天免疫活性与CD4 T细胞相关的HIV-1 DNA下降相关。
J Virol. 2015 Oct;89(20):10176-89. doi: 10.1128/JVI.01484-15. Epub 2015 Jul 29.
8
Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound.长期使用马拉维若可使潜伏的 HIV 在体内重新激活,但不能预防无抗逆转录病毒治疗的病毒反弹。
Sci Rep. 2020 Dec 18;10(1):22286. doi: 10.1038/s41598-020-79002-w.
9
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.自体 IgG 抗体阻止了 HIV-1 潜伏储库中相当大但可变比例的病毒的生长。
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32066-32077. doi: 10.1073/pnas.2020617117. Epub 2020 Nov 25.
10
Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.在抗逆转录病毒治疗期间产生残余病毒血症的细胞似乎会导致治疗中断后病毒血症反弹。
PLoS Pathog. 2020 Aug 25;16(8):e1008791. doi: 10.1371/journal.ppat.1008791. eCollection 2020 Aug.

引用本文的文献

1
Promotion of HIV clearance by sensitization of HIV reservoirs to cell death.通过使HIV储存库对细胞死亡敏感来促进HIV清除。
Front Immunol. 2025 Jul 14;16:1600741. doi: 10.3389/fimmu.2025.1600741. eCollection 2025.
2
Shedding dynamics of a DNA virus population during acute and long-term persistent infection.DNA病毒群体在急性和长期持续感染期间的脱落动态。
PLoS Pathog. 2025 May 23;21(5):e1013083. doi: 10.1371/journal.ppat.1013083. eCollection 2025 May.
3
Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.

本文引用的文献

1
Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19.支持基于自然杀伤细胞的疗法以减轻新冠肺炎中的肺部炎症。
Heliyon. 2021 Jul;7(7):e07635. doi: 10.1016/j.heliyon.2021.e07635. Epub 2021 Jul 21.
2
Tracking HIV Rebound following Latency Reversal Using Barcoded HIV.使用带有条码的 HIV 追踪潜伏逆转后 HIV 的反弹
Cell Rep Med. 2020 Dec 22;1(9):100162. doi: 10.1016/j.xcrm.2020.100162.
3
Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs .药理学激活非经典 NF-κB 信号可激活潜伏的 HIV-1 储库。
条形码标记的HIV-1揭示了由克隆增殖和独特表观遗传模式驱动的病毒持续性。
Nat Commun. 2025 Feb 14;16(1):1641. doi: 10.1038/s41467-025-56771-4.
4
Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells.泛半胱天冬酶抑制剂可诱导细胞因子预激活的自然杀伤细胞分泌HIV-1潜伏逆转剂淋巴毒素-α。
Cell Death Discov. 2025 Feb 4;11(1):44. doi: 10.1038/s41420-025-02330-1.
5
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV.替格洛纳醇替格列酸盐类似物作为用于根除HIV的潜伏逆转剂的合成及临床前评价
Sci Adv. 2025 Jan 24;11(4):eads1911. doi: 10.1126/sciadv.ads1911.
6
Pro-survival roles for p21(Cip1/Waf1) in non-small cell lung cancer.p21(Cip1/Waf1)在非小细胞肺癌中的促生存作用。
Br J Cancer. 2025 Mar;132(5):421-437. doi: 10.1038/s41416-024-02928-9. Epub 2024 Dec 20.
7
Interventions during Early Infection: Opening a Window for an HIV Cure?早期感染期的干预措施:为 HIV 治愈打开一扇窗?
Viruses. 2024 Oct 9;16(10):1588. doi: 10.3390/v16101588.
8
Topological Heterogeneity of Protein Kinase C Modulators in Human T-Cells Resolved with In-Cell Dynamic Nuclear Polarization NMR Spectroscopy.利用细胞内动态核极化 NMR 光谱技术解析人 T 细胞中蛋白激酶 C 调节剂的拓扑异质性。
J Am Chem Soc. 2024 Oct 9;146(40):27362-27372. doi: 10.1021/jacs.4c05704. Epub 2024 Sep 25.
9
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing.去岩藻糖基化的广泛中和抗体通过细胞介导的杀伤增强了对 HIV-1 感染细胞的清除。
Commun Biol. 2024 Aug 9;7(1):964. doi: 10.1038/s42003-024-06659-8.
10
Modelling HIV-1 control and remission.模拟HIV-1的控制与缓解
NPJ Syst Biol Appl. 2024 Aug 8;10(1):84. doi: 10.1038/s41540-024-00407-8.
Cell Rep Med. 2020 Jun 23;1(3):100037. doi: 10.1016/j.xcrm.2020.100037.
4
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.抗体和 TLR7 激动剂可延缓感染 SHIV 的猴子体内病毒反弹。
Nature. 2018 Nov;563(7731):360-364. doi: 10.1038/s41586-018-0600-6. Epub 2018 Oct 3.
5
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.人诱导多能干细胞来源的嵌合抗原受体修饰自然杀伤细胞增强抗肿瘤活性。
Cell Stem Cell. 2018 Aug 2;23(2):181-192.e5. doi: 10.1016/j.stem.2018.06.002. Epub 2018 Jun 28.
6
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.设计的、可合成获得的苔藓抑素类似物 HIV 潜伏逆转剂的表征。
Virology. 2018 Jul;520:83-93. doi: 10.1016/j.virol.2018.05.006. Epub 2018 May 26.
7
An advanced BLT-humanized mouse model for extended HIV-1 cure studies.用于延长 HIV-1 治愈研究的先进 BLT 人源化小鼠模型。
AIDS. 2018 Jan 2;32(1):1-10. doi: 10.1097/QAD.0000000000001674.
8
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.苔藓抑素1及其类似物的可扩展合成:抗潜伏性HIV的佐剂先导化合物
Science. 2017 Oct 13;358(6360):218-223. doi: 10.1126/science.aan7969.
9
NKG2CNKG2A Natural Killer Cells are Associated with a Lower Viral Set Point and may Predict Disease Progression in Individuals with Primary HIV Infection.NKG2C和NKG2A自然杀伤细胞与较低的病毒载量相关,并且可能预测原发性HIV感染个体的疾病进展。
Front Immunol. 2017 Sep 20;8:1176. doi: 10.3389/fimmu.2017.01176. eCollection 2017.
10
Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells.经人源化的自体人免疫细胞小鼠中,体外扩增的人自然杀伤细胞能够存活和增殖。
Sci Rep. 2017 Sep 21;7(1):12083. doi: 10.1038/s41598-017-12223-8.